LumeraFlow
Restoring dialysis access quickly, safely, and affordably.
Restoring dialysis access quickly, safely, and affordably.
Dialysis access clotting is one of the most common complications for patients with kidney failure. When grafts or fistulas clot, patients often require urgent procedures to restore blood flow before they can receive life-sustaining dialysis treatment.
Current thrombectomy technologies can be time consuming and costly, frequently requiring hospital based procedures and multiple attempts to clear the clot.
LumeraFlow’s catheter architecture is designed to safely restore blood flow while minimizing vessel trauma and improving procedural efficiency.
The technology is supported by a patent filing and an early working prototype under continued development.
Co-Founder and CEO
Vascular surgeon and innovator specializing in dialysis access care and vascular innovation.
Co-Founder and CTO
Mechanical engineer focused on medical device development, prototype testing, and device design.
LumeraFlow is seeking collaborators, clinical partners, and supporters interested in advancing dialysis access care.
Email: lumeraflowinc@gmail.com